Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness buys POC (point-of-care) firm for $33m:

This article was originally published in Clinica

Executive Summary

Inverness Medical Innovations has notched up its ninth acquisition of 2007, after buying point-of-care (POC) diagnostics distributor Bio-Stat Healthcare for $33.4m. Inverness will pay an earn-out of up to $14.6m based on Bio-Stat's 2007 financial results. Stockport, UK-based Bio-Stat, which recorded revenues of $29.5m in 2006, will provide Inverness with further presence in the European market after it purchased Promesan, an Italian POC test distributor in February (see Clinica No 1243, p 14). Inverness has also purchased Cholestech, Matritech, HemoSense, Biosite, Spectral Diagnostics, First Check Diagnostics and Med-Ox this year, as well as buying a 75% stake in Instant Technologies.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049912

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel